glp-1 news 2025 october 9 Looming drug patent expirations draw generics firms Rising use of GLP-1 medications

Aim for variety and a minimum of four to five servings per day

GLP-1 Receptor Agonists: Incretin Mimicry and Multi-System Effects GLP-1 receptor agonists (semaglutide, tirzepatide, dulaglutide) mimic glucagon-like peptide-1, a hormone released after nutrient intake

Safety and efficacy of an extended-release peptide YY analogue for obesity: A randomized, placebo-controlled, phase 1 trial

Breau M, Houssaini A, Lipskaia L, Abid S, Born E, Marcos E, Czibik G, Attwe A, Beaulieu D, Palazzo A, Flaman JM, Bourachot B, Collin G, Tran Van Nhieu J, Bernard My, Mechta-Grigoriou F, Adnot S

This depends on your specific device and body composition

It is used as adjuvant therapy to treat and prevent various medical conditions that arise from nutritional deficiencies or long term disorders